Skip Navigation

Aspartame Side Effects May Affect Heart and Brain Health: Study

Aspartame Side Effects May Affect Heart and Brain Health Study

New research indicates consuming less than 20% of the recommended daily dose of Equal, or other artificial sweeteners containing the ingredient aspartame, may cause concerning changes to the brain and the heart.

According to findings published in the journal Biomedicine & Pharmacotherapy, using aspartame helps people lose weight, yet may also lead to structural alterations in the heart and changes to brain function over a period of one year.

Artificial sweeteners like aspartame, known as Equal, or sucralose, known as Splenda, are used in hundreds of food products to sweeten them without the adverse health effects of actual sugar. Many products like baked goods, soda, chewing gum and fruit juice all contain artificial sweeteners, which can taste 200 times sweeter than sucrose, yet contain fewer calories.

Dangers of Artificial Sweeteners

While they are considered healthier alternatives to more natural options, prior research has highlighted the risks that artificial sweeteners like Equal and Splenda pose to human health.

A French study published in 2022 found that consuming less than two packets of Equal or Splenda per day increased a person’s risk of cardiovascular disease.  A separate study published last April concluded that using artificial sweeteners like Splenda may make users want to eat more food, potentially defeating one of the key reasons they are consumed. Artificial sweeteners can stimulate areas of the brain that control hunger, which may increase the risk of weight gain instead of weight loss.

The World Health Organization (WHO) even declared aspartame a possible carcinogen in 2023, after analyzing more than 1,000 studies. However, the U.S. Food and Drug Administration (FDA) rejected linking aspartame to increased cancer risks and disagreed with the WHO on setting acceptable daily limits.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

For the new study, Spanish researchers evaluated systemic effects of aspartame in male mice across one year. Led by Dr. Irati Aiestaran-Zelaia, the team exposed the mice to the dose equivalent of one-sixth of the recommended maximum human daily intake.

Mice received a daily dose of 7mg per kilogram of body weight in human equivalents. The maximum dose recommended by health authorities is 50 mg/kg per day.

Across one year, Equal helped to decrease body weight by 20%. However, consuming Equal was also linked with mild cardiac hypertrophy, which is a thickening of the heart muscle. Equal was also connected to neurobehavioral changes.

Researchers used MRIs, molecular imaging, brain and liver spectroscopy and cognitive tests to determine changes. They found that prolonged exposure to artificial sweeteners like Equal may come with physiological changes to the heart and the brain, warning that exposure to artificial sweeteners may impact the function of organs even when consumed in low doses.

“These findings indicate that while aspartame can help to achieve weight loss in mice, this is accompanied by pathophysiological changes in the heart and possibly in the brain. Thus, the study demonstrates that long-term exposure to artificial sweeteners can have a detrimental impact on organ function even at low doses, which suggests that current consumption guidelines should be critically re-examined.”

— Dr. Irati Aiestaran-Zelaia, Aspartame decreases fat deposits in mice at a cost of mild cardiac hypertrophy and reduced cognitive performance

The team concluded that the current recommended dose guidelines for artificial sweeteners should be reviewed and updated.

Sign up for more health and legal news that could affect you or your family.

Written By: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks.
A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims.
Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed.

About the writer

Martha Garcia

Martha Garcia

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.